Drugs / Adipocell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00992147 | May 2004 → Mar 2007 | — | Anterogen Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adipocell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00992147 ↗ |
| Known as | ANTG-adip | “autologous cultured adipocytes (ANTG-adip)” NCT00992147 ↗ |
| Modality | Cell therapy | “autologous cultured adipocytes (ANTG-adip)” NCT00992147 ↗ |
| Route | Subcutaneous | “Patients are given subcutaneous injection of ANTG-adip” NCT00992147 ↗ |